https://charts.traderzeitung.de/phases/US89455T1097
string(1376) "{"isin":"US89455T1097","name":"Treace Medical Concepts Inc","stock_id":19105690,"generated_at":"2026-10-22 06:17:00","days":[{"date":"2026-10-19","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.875,"close_at":"2026-10-19 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-10-20","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":4.05,"close_at":"2026-10-20 21:59:00","complete":true,"perf_pct":4.5161},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-10-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":4.13,"close_at":"2026-10-21 21:59:00","complete":true,"perf_pct":1.9753},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"
Treace Medical Concepts Aktie News & Nachrichten
Trading-Room

Treace Medical Concepts Aktie News & Nachrichten

[WKN: A3CM04 | Symbol: TMCI]
Realtimekurs
   
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Treace Medical Concepts

TOP-5-Kursziele der Analysten am 04.02.25

Jost Werke [DE000JST4000]: Hauck Aufhäuser IB bekräftigt Buy-Rating und erhöht das Kursziel von 70...

  • ‹
  • 1
  • ›
Treace Medical Concepts Nachrichtenticker öffnen
MT Newswires 10.08.2026 12:12 Uhr

Truist Securities erhöht Kursziel für Treace Medical Concepts von 4 $ auf 5 $, Rating bleibt Hold

06:11 AM EDT, 10.08.2026 (MT Newswires) -- Treace Medical Concepts (TMCI) hat laut von FactSet befragten Analysten ein durchschnittliches Rating von H

MT Newswires 16.07.2026 14:58 Uhr

Truist Securities passt Kursziel für Treace Medical Concepts von 2 $ auf 4 $ an, behält 'Hold'-Einstufung bei

08:57 AM EDT, 07/16/2026 (MT Newswires) -- Treace Medical Concepts (TMCI) hat laut von FactSet befragten Analysten eine durchschnittliche "Hold"-Einst

MT Newswires 28.05.2026 22:41 Uhr

Treace Medical Concepts Insider kaufte Aktien im Wert von 340.589 $, laut einer aktuellen SEC-Einreichung

04:40 PM EDT, 28.05.2026 (MT Newswires) -- John T. Treace, 10%-Eigentümer, Direktor, Chief Executive Officer, tätigte am 26. Mai 2026 einen Kauf von 1